Egle Therapeutics

Paris, France

Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.

Mar 2026

Grant

Biotechnology Health Care Oncology Therapeutics

Top Investors

BpifranceEQT Life SciencesEuropean CommissionFrance 2030Bioqube Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Egle Therapeutics

Who are Egle Therapeutics's investors?

Egle Therapeutics's investors include Bpifrance, EQT Life Sciences, European Commission, France 2030, Bioqube Ventures.

Where is Egle Therapeutics headquartered?

Egle Therapeutics is headquartered in Paris, France.

What does Egle Therapeutics do?

Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.

What stage is Egle Therapeutics at?

Egle Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 2, 2026.

MLA

"Egle Therapeutics — Funding & Investors." VCBacked, March 2, 2026, https://www.vcbacked.co/company/egle-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2026). Egle Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/egle-therapeutics

Wikipedia (cite web)

{{cite web |title=Egle Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/egle-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 2, 2026.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.